fda bpc 157 warning not approved bpc-157 compounding peptide safety unapproved risk fda bpc-157 exclude-ms-46062106116266

Many people struggle with hemorrhoids, fissures, or ongoing rectal inflammation. Traditional treatments don't always give lasting relief, which is why some of my clients have turned to a lesser-known option: using the

BPC-157 is a synthetic peptide based on a sequence found in human gastric juice

exclude-ms-46062106116266

Type:SubQ

From available case reports, compounding pharmacy data, and practitioner experience, the following have been observed: BPC-157 — Reported Side Effects Nausea and gastrointestinal discomfort (especially with oral administration) Dizziness or light-headedness Flushing or warmth at injection sites Headache Fatigue or somnolence in some users TB-500 — Reported Side Effects Injection site reactions (redness, mild pain, swelling) Transient fatigue or lethargy following administration Headache Possible flu-like symptoms in a minority of users Critical Risk Note: Because neither peptide has undergone full clinical trial evaluation in humans, the complete adverse event profile is unknown